1-19 of 19
Robert P. Hasserjian
Close
Sort by
Articles

Calibrating Personalized Risk in Patients With Clonal Hematopoiesis

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2024) 21 (1)
https://doi.org/10.1182/hem.V21.1.202411
Published: 2024
Articles

The Dynamics of Engraftment After Stem Cell Transplant: Clonal Expansion by Chance

Katelynn M. Wilton, MD, PhD, Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2023) 20 (6)
https://doi.org/10.1182/hem.V20.6.202361
Published: 2023
Articles

Artificial Intelligence Demonstrates Yet Another Talent: Classifying Myeloid Neoplasms

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2023) 20 (5)
https://doi.org/10.1182/hem.V20.5.202353
Published: 2023
Articles

Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2023) 20 (4)
https://doi.org/10.1182/hem.V20.4.202344
Published: 2023
Articles

Expanding the Repertoire in Myelodysplastic Syndromes: Studying the Sequence of Therapies in Lower-risk Transfusion-dependent Disease

Andrew M. Brunner, MD, Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2023) 20 (3)
https://doi.org/10.1182/hem.V20.3.202331
Published: 2023
Articles

Size Matters in Lymphoma Diagnosis Tissue Biopsy

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2023) 20 (2)
https://doi.org/10.1182/hem.V20.2.2023212
Published: 2023
Articles

This Year’s Best in Hematology Diagnosis: Mapping the Heterogeneity of Chronic Lymphocytic Leukemia

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2023) 20 (1)
https://doi.org/10.1182/hem.V20.1.202313
Published: 2023
Articles

The Seeds of Progression From Myelodysplastic Syndrome to Acute Myeloid Leukemia Are Sown Early in the Course of Disease

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2022) 19 (6)
https://doi.org/10.1182/hem.V19.6.202263
Published: 2022
Articles

In Response to Lymphohematopoietic Clones

David P. Steensma, MD, Rafael Bejar, MD, PhD, Siddhartha Jaiswal, MD, PhD, Mikkael A. Sekeres, MD, Robert P. Hasserjian, MD, Benjamin L. Ebert, MD, PhD
Journal: The Hematologist
The Hematologist (2022) 19 (5)
https://doi.org/10.1182/hem.V19.5.2022517
Published: 2022
Articles

IPSS-M Incorporates Next-Generation Sequencing for a New International Prognostic Scoring System

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2022) 19 (5)
https://doi.org/10.1182/hem.V19.5.202259
Published: 2022
Articles

ALK-positive Histiocytosis: An Old Target Shows Up in a New Disguise

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2022) 19 (4)
https://doi.org/10.1182/hem.V19.4.202241
Published: 2022
Articles

TP53 -mutated Acute Myeloid Leukemia and Myelodysplastic Syndrome With Excess Blasts: Two Sides of the Same Coin?

Robert Ta, MD, Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2022) 19 (3)
https://doi.org/10.1182/hem.V19.3.202231
Published: 2022
Articles

Survival of the Fittest: Hypomethylating Agent/BCL-2 Inhibitor Combination Versus Intensive Chemotherapy As Frontline Treatment for Acute Myeloid Leukemia

Michael J. Hochman, MD, Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2022) 19 (2)
https://doi.org/10.1182/hem.V19.2.202228
Published: 2022
Articles

This Year’s Best in Hematology Diagnosis: A New Disease Is Discovered

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2022) 19 (1)
https://doi.org/10.1182/hem.V19.1.2022117
Published: 2022
Articles

Separating Innocuous “CHIP” Mutations From Ominous “CHOP” Mutations in Patients With Treated AML in Remission

Megan J. Fitzpatrick, MD, Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2021) 18 (6)
https://doi.org/10.1182/hem.V18.6.202169
Published: 2021
Articles

Finding the True Hits in Double-Hit Lymphomas

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2021) 18 (5)
https://doi.org/10.1182/hem.V18.5.2021511
Published: 2021
Articles

Whole Genome Sequencing Provides Efficient and Comprehensive Genetic Risk Stratification in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2021) 18 (4)
https://doi.org/10.1182/hem.V18.4.202149
Published: 2021
Articles

A Perfect Storm: Chromosomal Alterations Cooperate With Clonal Hematopoiesis to Generate Therapy-Related Myeloid Neoplasia

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2021) 18 (3)
Published: 2021
Articles

Building a Model of Myelodysplastic Syndromes From the Ground Up

Robert P. Hasserjian, MD
Journal: The Hematologist
The Hematologist (2021) 18 (2)
Published: 2021